Advertisement

We need your help now

Support from readers like you keeps The Journal open.

You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to support our mission, but this year it has not been enough.

If you've seen value in our reporting, please contribute what you can, so we can continue to produce accurate and meaningful journalism. For everyone who needs it.

Peaches Geldof Matt Crossick/EMPICS Entertainment
Invention

Dublin entrepreneur gets Twitter shout-out from Peaches Geldof for baby invention

Bob Geldof’s daughter tweeted a photograph of her son using the baby-weaning device.

A DUBLIN-BASED COMPANY which makes products for babies has received a boost from an unexpected source – Peaches Geldof.

The 23-year-old daughter of Bob Geldof gave the thumbs up to a device which helps to wean babies onto soft foods by letting them suck it through a soother-type utensil.

She tweeted a photograph to her 139,495 Twitter followers of her 5-month old son Astala using the device.

“Grublet [her son's nickname] sucking on his new fave thing – his ClevaMama “ClevaFeed”. He loves it! And no this is not an endorsement!,” she tweeted on Sunday.

Dublin businesswoman Suzanne Browne, who set up the ClevaMama company with her sister, said the unexpected mention had been very good for the company.

“It’s obviously great for us that Peaches has said such nice things about the ClevaFeed and that she showed a picture of her little boy enjoying his food with it,” she said.

We’re delighted that she did – it can only be good news for the company as she is so high profile and it’s great that an Irish company that has created jobs here will get some exposure in Britain and further afield because of this.

Browne said she has already seen a surge in orders for the device.


Video: The Secret Millionaire returns tonight, here’s a sneak preview >

Your Voice
Readers Comments
21
    Submit a report
    Please help us understand how this comment violates our community guidelines.
    Thank you for the feedback
    Your feedback has been sent to our team for review.